Evidence map›Paper›PMID 42535251›Full record

ArticleJournal of the anus, rectum and colon2026

Feasibility of Consensus Molecular Subtype Classification of Colorectal Cancer Using Preoperative Biopsy Specimens: A Prospective Pilot Study (COLLAB Study).

Shunsuke Kasai, Keiichi Hatakeyama, Akio Shiomi, Kinichi Hotta, Shoichi Manabe, Kenichiro Imai, Yusuke Tanaka, Tadahiro Kojima, Keiichi Ohshima, Kenichi Urakami and 2 more

Abstract read
In one paragraph

Article in Journal of the anus, rectum and colon, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shunsuke KasaiDivision of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Keiichi HatakeyamaCancer Multiomics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
Akio ShiomiDivision of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Kinichi HottaDivision of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
Shoichi ManabeDivision of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Kenichiro ImaiDivision of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
Yusuke TanakaDivision of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Tadahiro KojimaDivision of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Keiichi OhshimaMedical Genetics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
Kenichi UrakamiCancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
Yasuto AkiyamaImmunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
Yusuke KinugasaDepartment of Gastrointestinal Surgery, Institute of Science Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The consensus molecular subtype (CMS) classification stratifies colorectal cancer (CRC) into four groups based on gene expression, offering potential for tailored therapy. This study evaluated the feasibility of CMS classification using preoperative biopsy specimens. Methods: This prospective pilot study enrolled eight patients with primary CRC (cT2 or deeper). In all cases, two biopsy specimens were obtained from different tumor regions during preoperative colonoscopy, using two forceps: forceps A (standard) and forceps B (jumbo). RNA yield and quality were measured, and CMS classification was conducted based on the microarray data. Concordance between a CMS classification of specimens obtained with the two forceps and the safety of the procedure were also examined. Results: Median patient age was 59 years; five were male. Tumor sites included two right-sided colon, two left-sided colon, and four rectal cancers. All biopsy procedures were performed safely without adverse events. Median RNA yield with forceps A was 210.20 (105.76-589.87) ng/μl, with an RNA integrity number (RIN) of 9.2 (7.8-9.9). For forceps B, median RNA yield was 295.99 (162.23-642.17) ng/μl, with a RIN of 9.1 (8.6-9.6). CMS classification was successfully achieved in all samples. Notably, in three of the eight patients, the CMS classifications differed between specimens collected using the two forceps. Conclusions: Preoperative biopsy specimens provided RNA of sufficient quality for CMS classification. However, intratumoral heterogeneity may lead to discordant classifications, and the results should therefore be interpreted cautiously. Further validation in larger cohorts is warranted.

Indexed as

colorectal cancerconsensus molecular subtypepreoperative biopsy

Identifiers

PMID42535251
PMCPMC13423445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.